These results suggested that the expression levels of EGFR and CXCR4 in serum sEVs may represent the expression levels of those in the primary tumor tissues, showing the potential of this easy flow cytometry-based protein profiling method in clinical application. This evidence concerns the gene CXCR4 and neoplasm.